These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 12639114)

  • 21. An unusual dinuclear ruthenium(III) complex with a conjugated bridging ligand derived from cleavage of a 1,4-dihydro-1,2,4,5-tetrazine ring. Synthesis, structure, and UV-vis-NIR spectroelectrochemical characterization of a five-membered redox chain incorporating two mixed-valence states.
    Patra S; Miller TA; Sarkar B; Niemeyer M; Ward MD; Lahiri GK
    Inorg Chem; 2003 Jul; 42(15):4707-13. PubMed ID: 12870962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ruthenium(II)-polyazine light absorbers bridged to reactive cis-dichlororhodium(III) centers in a bimetallic molecular architecture.
    Zigler DF; Wang J; Brewer KJ
    Inorg Chem; 2008 Dec; 47(23):11342-50. PubMed ID: 18980300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole.
    Reisner E; Arion VB; Guedes da Silva MF; Lichtenecker R; Eichinger A; Keppler BK; Kukushkin VY; Pombeiro AJ
    Inorg Chem; 2004 Nov; 43(22):7083-93. PubMed ID: 15500346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Syntheses, spectroscopic and molecular quadratic nonlinear optical properties of dipolar ruthenium(II) complexes of the ligand 1,2-phenylenebis(dimethylarsine).
    Coe BJ; Harries JL; Harris JA; Brunschwig BS; Coles SJ; Light ME; Hursthouse MB
    Dalton Trans; 2004 Sep; (18):2935-42. PubMed ID: 15349170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrocarbon oxidation by beta-halogenated dioxoruthenium(VI) porphyrin complexes: effect of reduction potential (RuVI/V) and C-H bond-dissociation energy on rate constants.
    Che CM; Zhang JL; Zhang R; Huang JS; Lai TS; Tsui WM; Zhou XG; Zhou ZY; Zhu N; Chang CK
    Chemistry; 2005 Nov; 11(23):7040-53. PubMed ID: 16163758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ruthenium polypyridine complexes of tris-(2-pyridyl)-1,3,5-triazine-unusual building blocks for the synthesis of photochemical molecular devices.
    Schwalbe M; Karnahl M; Görls H; Chartrand D; Laverdiere F; Hanan GS; Tschierlei S; Dietzek B; Schmitt M; Popp J; Vos JG; Rau S
    Dalton Trans; 2009 May; (20):4012-22. PubMed ID: 19440601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ruthenium(II) complexes containing 8-(dimethylphosphino)quinoline (Me(2)Pqn): preparation, crystal structures, and electrochemical and spectroscopic properties of [Ru(bpy or phen)(3)(-)(n)(Me(2)Pqn)(n)](PF(6))(2) (bpy = 2,2'-bipyridine; phen = 1,10-phenanthroline; n = 1, 2, or 3).
    Suzuki T; Kuchiyama T; Kishi S; Kaizaki S; Takagi HD; Kato M
    Inorg Chem; 2003 Feb; 42(3):785-95. PubMed ID: 12562192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dioxo-bridged dinuclear manganese(III) and -(IV) complexes of pyridyl donor tripod ligands: combined effects of steric substitution and chelate ring size variations on structural, spectroscopic, and electrochemical properties.
    Gultneh Y; Yisgedu TB; Tesema YT; Butcher RJ
    Inorg Chem; 2003 Mar; 42(6):1857-67. PubMed ID: 12639118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Replacement of chlorides with dicarboxylate ligands in anticancer active Ru(II)-DMSO compounds: a new strategy that might lead to improved activity.
    Bratsos I; Serli B; Zangrando E; Katsaros N; Alessio E
    Inorg Chem; 2007 Feb; 46(3):975-92. PubMed ID: 17257042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors affecting the electrochemical and spectroelectrochemical properties of diruthenium(III,II) complexes containing four identical unsymmetrical bridging ligands.
    Kadish KM; Wang LL; Thuriere A; Van Caemelbecke E; Bear JL
    Inorg Chem; 2003 Feb; 42(3):834-43. PubMed ID: 12562197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and characterization of two novel [Ru(bpy)(2)(phen)](2+)-based electrochemiluminescent labels.
    Wang P; Zhu G
    Luminescence; 2000; 15(4):261-5. PubMed ID: 10931640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of ruthenium(II) complexes of tetradentate bis(N-pyridylimidazolylidenyl)methane and their reactivities towards N- donors.
    Liu X; Chen W
    Dalton Trans; 2012 Jan; 41(2):599-608. PubMed ID: 22051596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variation of DNA photocleavage efficiency for [(TL)2Ru(dpp)]Cl2 complexes where TL=2,2'-bipyridine, 1,10-phenanthroline, or 4,7-diphenyl-1,10-phenanthroline.
    Mongelli MT; Heinecke J; Mayfield S; Okyere B; Winkel BS; Brewer KJ
    J Inorg Biochem; 2006 Dec; 100(12):1983-7. PubMed ID: 17095094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactivity, photolability, and computational studies of the ruthenium nitrosyl complex with a substituted cyclam fac-[Ru(NO)Cl2(κ3N4,N8,N11(1-carboxypropyl)cyclam)]Cl·H2O.
    Doro FG; Pepe IM; Galembeck SE; Carlos RM; da Rocha ZN; Bertotti M; Tfouni E
    Dalton Trans; 2011 Jun; 40(24):6420-32. PubMed ID: 21584321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and characterization of novel ferrocene-containing pyridylamine ligands and their ruthenium(II) complexes: electronic communication through hydrogen-bonded amide linkage.
    Kojima T; Noguchi D; Nakayama T; Inagaki Y; Shiota Y; Yoshizawa K; Ohkubo K; Fukuzumi S
    Inorg Chem; 2008 Feb; 47(3):886-95. PubMed ID: 18181616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of homoleptic and heteroleptic 2,2'-bipyridine and 1,10-phenanthroline ruthenium complexes as chemiluminescence and electrochemiluminescence reagents in aqueous solution.
    Cooke MM; Doeven EH; Hogan CF; Adcock JL; McDermott GP; Conlan XA; Barnett NW; Pfeffer FM; Francis PS
    Anal Chim Acta; 2009 Mar; 635(1):94-101. PubMed ID: 19200484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mixed-ligand complexes of ruthenium(II) containing new photoactive or electroactive ligands: synthesis, spectral characterization and DNA interactions.
    Ghosh T; Maiya BG; Samanta A; Shukla AD; Jose DA; Kumar DK; Das A
    J Biol Inorg Chem; 2005 Aug; 10(5):496-508. PubMed ID: 15981005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, molecular structure, and C-C coupling reactions of carbeneruthenium(II) complexes with C5H5Ru(=CRR') and C5Me5Ru(=CRR') as molecular units.
    Braun T; Münch G; Windmüller B; Gevert O; Laubender M; Werner H
    Chemistry; 2003 Jun; 9(11):2516-30. PubMed ID: 12794894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents.
    Cini R; Tamasi G; Defazio S; Corsini M; Zanello P; Messori L; Marcon G; Piccioli F; Orioli P
    Inorg Chem; 2003 Dec; 42(24):8038-52. PubMed ID: 14632524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ruthenium complexes of thiaporphyrin and dithiaporphyrin.
    Chuang CH; Ou CK; Liu ST; Kumar A; Ching WM; Chiang PC; dela Rosa MA; Hung CH
    Inorg Chem; 2011 Dec; 50(23):11947-57. PubMed ID: 22059653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.